EcoDrugPlus

Ribosomal Protein Lateral Stalk Subunit P0

Ensembl ID : ENSSLUG00000003899
Gene Symbol: RPLP0
3 Cross references
398 Possible Orthologues:

Ribosomal Protein Lateral Stalk Subunit P1

Ensembl ID : ENSSLUG00000001213
Gene Symbol: RPLP1
3 Cross references
382 Possible Orthologues:

Secretin Receptor

Ensembl ID : ENSSLUG00000025611
Gene Symbol: SCTR
1 Cross references
130 Possible Orthologues:

Selectin E

Ensembl ID : ENSSLUG00000016605
Gene Symbol: SELE
1 Cross references
182 Possible Orthologues:

Selectin P

Ensembl ID : ENSSLUG00000016635
Gene Symbol: SELP
1 Cross references
49 Possible Orthologues:

Serine/arginine Repetitive Matrix Protein 1-Like

Ensembl ID : ENSSLUG00000000095
Gene Symbol: LOC116042761
2 Cross references
190 Possible Orthologues:

Serine/threonine-Protein Kinase Pim-1-Like

Ensembl ID : ENSSLUG00000019715
Gene Symbol: LOC116040887
3 Cross references
246 Possible Orthologues:

Serpin Family C Member 1

Ensembl ID : ENSSLUG00000017598
Gene Symbol: SERPINC1
3 Cross references
199 Possible Orthologues:

Serum Amyloid P-Component-Like

Ensembl ID : ENSSLUG00000011011
Gene Symbol: LOC116049527
2 Cross references
354 Possible Orthologues:

Si:dkey-211g8.6

Ensembl ID : ENSSLUG00000000704
Gene Symbol: SI:DKEY-211G8.6
1 Cross references
320 Possible Orthologues:

Sigma Non-Opioid Intracellular Receptor 1

Ensembl ID : ENSSLUG00000023185
Gene Symbol: SIGMAR1
3 Cross references
204 Possible Orthologues:

Smoothened, Frizzled Class Receptor

Ensembl ID : ENSSLUG00000025728
Gene Symbol: SMO
3 Cross references
204 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).